Septic Pelvic Thrombophlebitis with Septic Pulmonary Emboli
The most likely diagnosis is septic pelvic thrombophlebitis (SPT), specifically involving ovarian vein thrombophlebitis (OVT) with septic pulmonary emboli, in the setting of retained products of conception and postpartum endometritis.
Clinical Reasoning
This 35-year-old postpartum patient presents with the classic triad that defines SPT:
- Persistent high-grade fever (15 days, 5-6 spikes/day) refractory to multiple antibiotics including piperacillin-tazobactam
- Imaging confirmation of retained products of conception (RPOC) with bulky uterus and heterogeneous endometrial content
- Partial inferior vena cava thrombosis on CECT
- Centrilobular nodules in bilateral lungs consistent with septic pulmonary emboli
The imaging constellation is pathognomonic: hepatosplenomegaly with portal hypertension, dilated fallopian tubes suggesting salpingitis, ascites, and most critically, IVC thrombosis with pulmonary nodules representing septic emboli 1, 2, 3.
Why This Diagnosis Fits
Postpartum SPT occurs in 0.01-0.02% of vaginal deliveries but presents exactly as this case demonstrates 1, 4. The key diagnostic features present here include:
- Fever persisting beyond 72 hours of appropriate antibiotics - the hallmark of SPT that distinguishes it from simple endometritis 2, 3
- RPOC serving as the infectious nidus - retained tissue provides the substrate for bacterial seeding of pelvic veins 5, 6
- Thrombosis extending to IVC - indicates advanced disease with high embolic risk 4, 3
- Septic pulmonary emboli - the centrilobular lung nodules represent infected thrombi that have embolized from the pelvic venous system 1, 2
Critical Management Algorithm
Immediate triple therapy is mandatory 7, 8:
1. Broad-Spectrum Antibiotics
- Continue or escalate to carbapenem-based regimen (meropenem or imipenem) given failure of piperacillin-tazobactam 3, 6
- Add coverage for MRSA and anaerobes if not already included
- Duration: minimum 4-6 weeks of IV therapy given septic emboli 1, 2
2. Therapeutic Anticoagulation
- Low-molecular-weight heparin (LMWH) is the drug of choice postpartum 7
- Dosing: enoxaparin 1 mg/kg twice daily or dalteparin 100 IU/kg twice daily 7
- Target anti-Xa levels: 0.6-1.2 IU/mL at 4-6 hours post-dose 7
- Duration: minimum 3-6 months, potentially longer given IVC involvement 7
- Transition to warfarin (INR 2-3) is acceptable postpartum as warfarin is safe for breastfeeding 7, 9
3. Source Control - Uterine Evacuation
- Urgent dilation and curettage to remove RPOC is essential 10, 11
- The avascular RPOC on ultrasound confirms this is appropriate (not a vascular malformation requiring embolization) 10, 12
- Perform only after initiating anticoagulation and antibiotics to minimize embolic risk
Additional Considerations
VTE prophylaxis is critical in septic pregnant/postpartum patients - the risk of VTE in sepsis can reach 37%, and this patient already has established thrombosis 8.
The hepatosplenomegaly with portal hypertension likely represents septic portal vein involvement (pylephlebitis) - an extension of the pelvic septic thrombophlebitis 9. This further supports aggressive anticoagulation.
The bilateral salpingitis indicates ascending infection from the endometritis, creating the perfect environment for venous seeding 5, 3.
Common Pitfalls to Avoid
- Do not delay anticoagulation waiting for complete infection control - both must occur simultaneously 1, 2, 3
- Do not perform curettage before imaging rules out uterine arteriovenous malformation, which would hemorrhage catastrophically 12
- Do not stop antibiotics when fever resolves - septic emboli require prolonged therapy (4-6 weeks minimum) 1, 2
- Do not use unfractionated heparin unless delivery is imminent - LMWH has superior safety profile postpartum 7, 8
Prognosis
With appropriate triple therapy (antibiotics + anticoagulation + source control), mortality is low in modern series 4, 2, 3. However, delayed diagnosis historically carried mortality rates of 4-5% 13. The presence of septic pulmonary emboli indicates advanced disease requiring ICU-level monitoring 8, 2.
Hematology referral is mandatory to evaluate for underlying thrombophilia (factor V Leiden, prothrombin G20210A mutation) which may have predisposed to this complication 14, 2.